Le Lézard
Classified in: Health, Covid-19 virus
Subject: MRR

Global Respiratory Monitoring and Therapeutic Devices Market Report 2022: Future Growth Potential of Respiratory Devices due to Their Rising Demand in Home Care Settings


DUBLIN, Feb. 2, 2023 /PRNewswire/ -- The "Global Respiratory Monitoring Solutions Witness Technological and Business Model Evolution" report has been added to  ResearchAndMarkets.com's offering.

Research and Markets Logo


This study examines the respiratory device market and includes respiratory monitoring and therapeutic devices. Respiratory device end users, including hospitals, physician offices, nursing homes, sleep laboratories, ambulatory surgical centers, and home care settings, are considered for this study.

The COVID-19 pandemic significantly increased the demand for respiratory devices, such as ventilators, oxygen concentrators, and pulse oximeters. In addition, home care device demand rose due to the growing burden on healthcare resources, and it is estimated to drive the respiratory device market.

Across the world, more than 900, 330, and 380 million people suffer from sleep apnea, asthma, and chronic obstructive pulmonary disorder, respectively, and this high disease burden drives the respiratory monitoring device market. Although the prevalence of different chronic respiratory diseases is high, a large population pool is undiagnosed, especially in South Asia, Latin America, and Africa. Public and private organization initiatives are estimated to increase awareness, diagnosis, and treatment rates.

Patient adherence is a major challenge, and respiratory monitoring device industry vendors are developing various software platforms and apps to address it, increase patient engagement, and provide education related to therapies and disease management.

In addition, key stakeholders are introducing technologically advanced devices, such as wearables, artificial intelligence (AI)-/machine learning (ML)-integrated devices, and connected devices, to increase patient adoption. Respiratory devices are continuously modified to be portable, small, connected, and smart. These technological advancements are estimated to drive market growth potential.

In addition, the report includes the following:

Key Topics Covered:

1. Strategic Imperatives

2. Growth Opportunity Analysis

3. Growth Opportunity Analysis - PAP Devices

4. Growth Opportunity Analysis - Oxygen Concentrators

5. Growth Opportunity Analysis - Capnography Devices

6. Growth Opportunity Analysis - Pulse Oximeters

7. Growth Opportunity Analysis - Spirometers

8. Growth Opportunity Analysis - Polysomnography Devices

9. Growth Opportunity Analysis - Peak Flow Meters

10. Growth Opportunity Universe

11. Next Steps

For more information about this report visit https://www.researchandmarkets.com/r/etg7s2

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]
 
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
 
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

SOURCE Research and Markets


These press releases may also interest you

19 avr 2024
Voxtur Analytics Corp. , a North American technology company creating a more transparent and accessible real estate lending ecosystem, is pleased to announce that it has engaged the services of ICP Securities Inc. ("ICP") to provide automated market...

19 avr 2024
On April 19, 2024, the board of directors of Portland General Electric Company declared a quarterly common stock dividend of $0.50 per share, representing an increase of 5.3%, or $0.10 per share, on an annualized basis. The company's dividend is...

19 avr 2024
Adyton Resources Corporation  ("Adyton" or the "Company") announces it has closed its previously announced non-brokered private placement offering, pursuant to which it has issued 50,000,000 common shares of the Company ("Shares") at a price of...

19 avr 2024
Building on a successful phase one in which STChealth proved that the Universal Patient Identifier (UPI)?powered by Experian Health's Universal Identity Manager (UIM) and NCPDP Standardstm?can accurately identify patients across multiple datasets in...

19 avr 2024
Lion Group Holding Ltd. ("Lion" or "the Company") , the operator of an all-in-one trading platform that offers a wide spectrum of products and services, today announced that on April 18, 2024, it received a delinquency notification letter from the...

19 avr 2024
Cosmos Health Inc. ("Cosmos Health" or the "Company'') , a diversified, vertically integrated global healthcare group engaged in innovative R&D, owner of proprietary pharmaceutical and nutraceutical brands, manufacturer and distributor...



News published on and distributed by: